NO20003881L - Bibapcitid-baserte farmasøytiske sammensetninger for avbildning og behandling av thromber - Google Patents

Bibapcitid-baserte farmasøytiske sammensetninger for avbildning og behandling av thromber

Info

Publication number
NO20003881L
NO20003881L NO20003881A NO20003881A NO20003881L NO 20003881 L NO20003881 L NO 20003881L NO 20003881 A NO20003881 A NO 20003881A NO 20003881 A NO20003881 A NO 20003881A NO 20003881 L NO20003881 L NO 20003881L
Authority
NO
Norway
Prior art keywords
bibapcitide
thrombi
imaging
treatment
pharmaceutical compositions
Prior art date
Application number
NO20003881A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003881D0 (no
Inventor
Richard T Dean
John Lister-James
Original Assignee
Diatide Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9802681A external-priority patent/GB9802681D0/en
Application filed by Diatide Inc filed Critical Diatide Inc
Publication of NO20003881D0 publication Critical patent/NO20003881D0/no
Publication of NO20003881L publication Critical patent/NO20003881L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20003881A 1998-02-06 2000-07-28 Bibapcitid-baserte farmasøytiske sammensetninger for avbildning og behandling av thromber NO20003881L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/020,086 US6028056A (en) 1998-02-06 1998-02-06 Pharmaceutical compositions for imaging and treating thrombi
GB9802681A GB9802681D0 (en) 1998-02-06 1998-02-06 Pharmaceutical compoations for imaging and treating thrombi
PCT/US1999/002583 WO1999039747A1 (en) 1998-02-06 1999-02-05 Bipapcitide-based pharmaceutical compositions for imaging and treating thrombi

Publications (2)

Publication Number Publication Date
NO20003881D0 NO20003881D0 (no) 2000-07-28
NO20003881L true NO20003881L (no) 2000-07-28

Family

ID=26313082

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20003881A NO20003881L (no) 1998-02-06 2000-07-28 Bibapcitid-baserte farmasøytiske sammensetninger for avbildning og behandling av thromber

Country Status (26)

Country Link
US (1) US6028056A (ja)
EP (1) EP1053027B1 (ja)
JP (1) JP2003532617A (ja)
KR (1) KR100452390B1 (ja)
CN (1) CN1103606C (ja)
AR (1) AR018546A1 (ja)
AT (1) ATE279214T1 (ja)
AU (1) AU761778B2 (ja)
BR (1) BR9908352A (ja)
CA (1) CA2319544C (ja)
DE (1) DE69921096T2 (ja)
DK (1) DK1053027T3 (ja)
EA (1) EA005406B1 (ja)
ES (1) ES2229681T3 (ja)
HK (1) HK1032198A1 (ja)
HU (1) HUP0100887A3 (ja)
IL (1) IL137076A (ja)
NO (1) NO20003881L (ja)
NZ (1) NZ505085A (ja)
PE (1) PE20000250A1 (ja)
PL (1) PL342253A1 (ja)
PT (1) PT1053027E (ja)
SI (1) SI1053027T1 (ja)
SK (1) SK284463B6 (ja)
TW (1) TWI246425B (ja)
WO (1) WO1999039747A1 (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY174617A (en) 2011-08-17 2020-05-01 Life Molecular Imaging Sa Compounds for binding to the platelet specific glycoprotein iib/iiia and their use for imaging of thrombi
US20160008490A1 (en) 2013-02-12 2016-01-14 Bayer Pharma Aktiengesellschaft Metal chelate compounds for binding to the platelet specific glycoprotein iib/iiia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830856A (en) * 1991-02-08 1998-11-03 Diatide, Inc. Radiolabeled compounds for thrombus imaging
US5645815A (en) * 1991-02-08 1997-07-08 Diatide, Inc. Radiolabled compounds for thrombus imaging
US5508020A (en) * 1992-06-05 1996-04-16 Diatech, Inc. Technetium-99M labeled peptides for imaging
DK0641222T3 (da) * 1992-05-21 2000-12-11 Diatide Inc Peptider mærket med technetium-99m til trombeafbildning

Also Published As

Publication number Publication date
BR9908352A (pt) 2000-11-28
EP1053027A1 (en) 2000-11-22
KR100452390B1 (ko) 2004-10-08
WO1999039747A1 (en) 1999-08-12
HK1032198A1 (en) 2001-07-13
KR20010040676A (ko) 2001-05-15
AU2660499A (en) 1999-08-23
AR018546A1 (es) 2001-11-28
DE69921096T2 (de) 2006-02-02
IL137076A0 (en) 2001-06-14
NZ505085A (en) 2002-10-25
PT1053027E (pt) 2005-01-31
AU761778B2 (en) 2003-06-12
DK1053027T3 (da) 2005-01-17
NO20003881D0 (no) 2000-07-28
HUP0100887A3 (en) 2003-08-28
EA005406B1 (ru) 2005-02-24
CA2319544C (en) 2006-07-04
CN1290179A (zh) 2001-04-04
SI1053027T1 (en) 2005-04-30
US6028056A (en) 2000-02-22
TWI246425B (en) 2006-01-01
EA200000820A1 (ru) 2001-02-26
CA2319544A1 (en) 1999-08-12
JP2003532617A (ja) 2003-11-05
IL137076A (en) 2004-08-31
PL342253A1 (en) 2001-06-04
SK284463B6 (sk) 2005-04-01
CN1103606C (zh) 2003-03-26
DE69921096D1 (de) 2004-11-18
ATE279214T1 (de) 2004-10-15
ES2229681T3 (es) 2005-04-16
SK11392000A3 (sk) 2001-03-12
HUP0100887A2 (hu) 2001-06-28
PE20000250A1 (es) 2000-06-02
EP1053027B1 (en) 2004-10-13

Similar Documents

Publication Publication Date Title
Endo et al. Classification of Barrett's epithelium by magnifying endoscopy
NO20016427L (no) Blandinger og fremgangsmåter for behandling av diagnose av lungekreft
Aslan et al. Cold snare polypectomy versus hot snare polypectomy in endoscopic treatment of small polyps
EA003398B1 (ru) Лекарственный комплекс c полимерным носителем
WO2002066511A3 (en) Long lasting glucagon-like peptide 2 (glp-2) for the treatment of gastrointestinal diseases and disorders
EP1547996A4 (en) DIAGNOSTIC PROBES AND REMEDIES FOR DISEASES HAVING PRION PROTEIN ACCUMULATION AND METHOD OF MARKING
DE60116313D1 (de) Verbindungen zur behandlung der alzheimerischen krankheit
Gounaris et al. Fluorescence endoscopy of cathepsin activity discriminates dysplasia from colitis
DE60214134D1 (de) Modifizierte psma-liganden und deren verwendung
TR201909741T4 (tr) Kolon temizleme bileşimleri.
EA200600524A1 (ru) Способы лечения эндометриоза
HUP0300534A2 (hu) Tumorellenes ekteinaszcidinszármazékok és ezeket tartalmazó gyógyszerkészítmények
TNSN00108A1 (fr) Derives d'erythromycine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
WO2001035950A3 (en) Benzamide therapeutics and methods for treating inflammatory bowel disease
WO2002055988A3 (en) Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators
DE60127986D1 (de) Bildgebende verfahren, diagnose und behandlung von krankheiten
CA3207999A1 (en) Bivalent fibroblast activation protein ligands for targeted delivery applications
WO2004064869A3 (en) Amyloid-binding, metal-chelating agents
EE200000587A (et) Uued 15-lülilised ketoasaliidid, meetod nende valmistamiseks ning neid sisaldav farmatseutiline kompositsioon kasutamiseks bakternakkuste ravis
ITMI20011708A0 (it) Coniugati di peptidi, loro derivati con complessi metallici e utilizzo per i'indagine diagnostica tramite imaging per risonanza magnetica(m
ATE241141T1 (de) Behandlung und diagnose helicobacter pylori infektionen
NO20003881L (no) Bibapcitid-baserte farmasøytiske sammensetninger for avbildning og behandling av thromber
Leskinen Complications of acute otitis media in children
JPWO2016006678A1 (ja) ジペプチジルペプチダーゼiv検出用蛍光プローブ
Matsuda et al. Screening colonoscopy: What is the most reliable modality for the detection and characterization of colorectal lesions?

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application